Sphingolipids and expression regulation of genes in cancer.
about
Identification of sphingolipid metabolites that induce obesity via misregulation of appetite, caloric intake and fat storage in DrosophilaCeramide glycosylation catalyzed by glucosylceramide synthase and cancer drug resistance.Ceramide modulates pre-mRNA splicing to restore the expression of wild-type tumor suppressor p53 in deletion-mutant cancer cells.(1)H NMR Metabolomics Study of Metastatic Melanoma in C57BL/6J Mouse Spleen.Suppression of glucosylceramide synthase restores p53-dependent apoptosis in mutant p53 cancer cells.Sphingolipid signaling and hematopoietic malignancies: to the rheostat and beyond.Lipin-1 phosphatidic phosphatase activity modulates phosphatidate levels to promote peroxisome proliferator-activated receptor γ (PPARγ) gene expression during adipogenesis.Metastatic Melanoma Induced Metabolic Changes in C57BL/6J Mouse Stomach Measured by 1H NMR Spectroscopy.Triangulated mal-signaling in Alzheimer's disease: roles of neurotoxic ceramides, ER stress, and insulin resistance reviewedUtilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosisThe opposite effects of doxorubicin on bone marrow stem cells versus breast cancer stem cells depend on glucosylceramide synthaseMetronomic ceramide analogs inhibit angiogenesis in pancreatic cancer through up-regulation of caveolin-1 and thrombospondin-1 and down-regulation of cyclin D1.An increase in glucosylceramide synthase induces Bcl-xL-mediated cell survival in vinorelbine-resistant lung adenocarcinoma cells.Ceramide glycosylation by glucosylceramide synthase selectively maintains the properties of breast cancer stem cells.Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury.Lipidomics of glycosphingolipids.Studies of Secondary Melanoma on C57BL/6J Mouse Liver Using 1H NMR MetabolomicsThree serum metabolite signatures for diagnosing low-grade and high-grade bladder cancer.Resuscitating wild-type p53 expression by disrupting ceramide glycosylation: a novel approach to target mutant p53 tumors.Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.Glycosphingolipids: synthesis and functions.Roles of galactose 3'-O- sulfation in signaling.Sphingolipids and mitochondrial apoptosis.Autophagic flux and autophagosome morphogenesis require the participation of sphingolipids.Modulation of alternative splicing by anticancer drugs.Cellular effects of fluorodeoxyglucose: Global changes in the lipidome and alteration in intracellular transport.Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?Sphingolipids regulate telomere clustering by affecting the transcription of genes involved in telomere homeostasis.Altered Leukocyte Sphingolipid Pathway in Breast Cancer.Single oocyte and single embryo lipid analysis by desorption electrospray ionization mass spectrometry.Sphingosine but not sphingosine-1-phosphate stimulates suicidal erythrocyte death.Sphingosine kinase 1 overexpression is associated with poor prognosis and oxaliplatin resistance in hepatocellular carcinoma.
P2860
Q28536054-D1986E11-AB02-4964-AD8D-35C84CF6967DQ33733991-240650CE-510D-4D04-9754-61934C465F32Q34302149-82BEFE67-7E8E-4F6C-BE66-9A3FFA9ADC1BQ34453064-38E9F3B2-B443-48F5-B095-E3140187FE17Q34687279-9C0ED6C1-20CF-46C2-AFDA-2C57D45817D6Q35675184-4473DDCC-03A5-4845-8746-14334947E630Q35728497-30E3CD59-25D1-4779-BDF1-177B6DCE59BCQ35911466-E7169211-35AF-4F9B-B997-2EBAEA2D7AEAQ35997884-0471743B-BE15-45A6-9F91-7C3FE4E55140Q36165635-DD78E2AA-8A13-436A-B563-2066B46BFF1AQ36269159-24580F90-8F01-422E-8147-C2483E34D7B8Q36282739-483A2581-B634-4AFC-813C-DA26F026225CQ36299738-A0CC99D3-EFC4-42DA-8E2C-68229C27652EQ36347787-6611E3F7-CD53-43BE-96F3-58E4E905FAADQ37056490-D06AA710-ACD2-4BD1-8021-5198A0DF1DA4Q37512584-00EFF64D-36EF-4DBA-BA60-5F100A25EFF4Q37608810-9EB50B8C-13B2-49CE-8E9C-12583DC985C5Q37739690-4CC350C9-EA9D-4AD1-9D19-6BC4B8822D07Q37942529-B0F91F11-A464-4344-8834-B3CFF9F5F923Q38052818-750BF3FB-77D4-4C65-AB8D-098FC25C7D47Q38155963-4E9D1B32-2CD2-4A70-8BB4-A9AA6AD6FABEQ38258043-DDB2363F-F664-4D58-A08C-39436A5628E0Q38332040-84DD3BB3-8237-4CFE-BA4A-D13F9FA52EDEQ38361932-C763D671-5E96-4EC7-BD88-5DFB6F980E0DQ38443362-BDCD9076-D825-4169-AF3E-0E74ABB4A3D1Q39201102-663DD030-C4E4-42E4-8765-4D92176F3FADQ39421907-AD858ECD-7A7C-4979-8CE2-0ECA9A0CA281Q40867505-102574E3-0C13-43B0-A9F9-3583DD0CD066Q46135175-B00BAC8D-8698-43A8-9B8D-58CC9A2C750DQ48656561-BC073DCC-DD16-4BDA-BEFD-15CA239CD738Q54565672-FAF4CF1D-DBC2-4FE2-AD6A-991EEC1C7037Q54977790-822179F5-32FB-4D5B-9FEA-DE356F170F08
P2860
Sphingolipids and expression regulation of genes in cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sphingolipids and expression regulation of genes in cancer.
@en
Sphingolipids and expression regulation of genes in cancer.
@nl
type
label
Sphingolipids and expression regulation of genes in cancer.
@en
Sphingolipids and expression regulation of genes in cancer.
@nl
prefLabel
Sphingolipids and expression regulation of genes in cancer.
@en
Sphingolipids and expression regulation of genes in cancer.
@nl
P2860
P1476
Sphingolipids and expression regulation of genes in cancer
@en
P2093
Gauri A Patwardhan
P2860
P304
P356
10.1016/J.PLIPRES.2010.10.003
P50
P577
2010-10-21T00:00:00Z